• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problem Difficult to Open or Close (2921)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 04/23/2021
Event Type  Injury  
Event Description
On (b)(6) 2021, a perceval valve pvs23 was implanted as part of an avr procedure.A concomitant cabg procedure was also performed.The ascending aorta dimension was 4.6 but had a nice waist at stj, deemed appropriate for the perceval valve given the annulus size.The valve deployment was performed uneventfully and the sinuses held saline without pvl after balloon.Good position was confirmed.The crossclamp was removed and the lv dilated severely.Wide open aortic insufficiency central was noted on the tee.The valve explanted and inspected.It was thought one leaflet looked less redundant than the other 2.A size 21 inspiris placed instead and patient is doing well.
 
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model #icv1209, s/n # (b)(6), as they pertain to the reported event, were retrieved and reviewed by the manufacturer's quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1209) perceval heart valve at the time of manufacture and release.The documentation included the steady flow test performed at the time of valve release.This review confirmed an acceptable opened and closed leaflet performance of the perceval pvs23 sn# a97452.No anomalies are observed during the open/close cycle.The valve therefore meets the acceptance criteria of the steady flow test inspection defined in principal device function test at the time of release.Since the device was not returned to the manufacturer no further investigation was possible at this time.Based on the available information, it is not possible to draw a definitive conclusion for the reported event.However, from the document review performed, no manufacturing deficiencies were identified.Considering the labelled dimensions of the perceval valve pvs23 (id 21-23mm) and the ones of the inspiris size 21 (id 20mm), a slight oversizing may have occurred.However, this was not confirmed based on the information received (i.E.''the ascending aorta dimension was 4.6 but had a nice waist at stj, deemed appropriate for the perceval valve given the annulus size'').Ultimately, given that the device was not returned and no further information was provided despite the attempts of follow up, the root cause remains unknown at this time.Although the device was initially made available for return, it was not received after more than 90 days.As such, no further investigation is possible.Should the device be returned at a later stage, or should further information become available in the future, the manufacturer will provide an update to this reporting activity.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
MDR Report Key11874348
MDR Text Key252317465
Report Number3004478276-2021-00161
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)230610
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/10/2023
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/26/2021
Initial Date FDA Received05/25/2021
Supplement Dates Manufacturer Received12/31/2021
Supplement Dates FDA Received01/21/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/10/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-